Santhera Pharmaceuticals (SPHDF) Q3 2024 Earnings

Sep 12Confirmed
Mar 2021
Jun 2021
Q2 2024
Q3 2024
-1.5
-1
-0.5
0

Details

Expected EPS
N/A
Actual EPS
-1.501605
Surprise EPS
N/A
Surprise Percent
N/A

Description

⁨Santhera Pharmaceuticals⁩ (⁦SPHDF⁩) has reported earnings of ⁦-1.501605⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts